DK1891942T3 - Ophthalmic action and method for prolonged delivery of a drug to the eye - Google Patents

Ophthalmic action and method for prolonged delivery of a drug to the eye

Info

Publication number
DK1891942T3
DK1891942T3 DK07012726.1T DK07012726T DK1891942T3 DK 1891942 T3 DK1891942 T3 DK 1891942T3 DK 07012726 T DK07012726 T DK 07012726T DK 1891942 T3 DK1891942 T3 DK 1891942T3
Authority
DK
Denmark
Prior art keywords
eye
pore
insert
body portion
medication
Prior art date
Application number
DK07012726.1T
Other languages
Danish (da)
Inventor
Bruce E Cohan
Howard Diamond
Original Assignee
Eyelab Group Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23134640&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1891942(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eyelab Group Llc filed Critical Eyelab Group Llc
Application granted granted Critical
Publication of DK1891942T3 publication Critical patent/DK1891942T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Abstract

An ophthalmic insert (24) and method for sustained release of medication to the eye are provided. The insert (24) includes a body portion (30) sized to pass through a lacrimal punctum (14, 16) and be positioned within a lacrimal canaliculus (18, 20) of the eyelid. The insert further includes a collarette (26) connected to the body portion (30) and sized to rest on the exterior of the lacrimal punctum, the collarette having a pore (42) provided therein. A reservoir (34) is contained at least partially within the body portion (30) and in fluid communication with the pore (42), wherein the reservoir (34) is designed to store and release medication through the pore (42) and onto the eye over time in a controlled manner while the insert (24) is positioned in the eyelid. Preferably, the pore (42) is constructed with a specific geometry appropriate to control the rate of release of the medication onto the eye.
DK07012726.1T 1999-04-19 2000-04-07 Ophthalmic action and method for prolonged delivery of a drug to the eye DK1891942T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/294,720 US6196993B1 (en) 1998-04-20 1999-04-19 Ophthalmic insert and method for sustained release of medication to the eye
EP00921783A EP1178779B1 (en) 1999-04-19 2000-04-07 Ophthalmic insert and method for sustained release of medication to the eye

Publications (1)

Publication Number Publication Date
DK1891942T3 true DK1891942T3 (en) 2010-06-07

Family

ID=23134640

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00921783T DK1178779T3 (en) 1999-04-19 2000-04-07 Ophthalmic insert and procedure for prolonged delivery of drug to the eye
DK07012726.1T DK1891942T3 (en) 1999-04-19 2000-04-07 Ophthalmic action and method for prolonged delivery of a drug to the eye

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK00921783T DK1178779T3 (en) 1999-04-19 2000-04-07 Ophthalmic insert and procedure for prolonged delivery of drug to the eye

Country Status (9)

Country Link
US (1) US6196993B1 (en)
EP (2) EP1891942B1 (en)
AT (2) ATE459343T1 (en)
AU (1) AU4205900A (en)
DE (2) DE60043959D1 (en)
DK (2) DK1178779T3 (en)
ES (2) ES2340616T3 (en)
PT (2) PT1178779E (en)
WO (1) WO2000062760A1 (en)

Families Citing this family (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20050119737A1 (en) * 2000-01-12 2005-06-02 Bene Eric A. Ocular implant and methods for making and using same
US20040175410A1 (en) * 2000-04-26 2004-09-09 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
US20040208910A1 (en) * 2000-04-26 2004-10-21 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of adrenergic agents
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU3649502A (en) 2000-11-29 2002-06-11 Oculex Pharm Inc Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
DE60239868D1 (en) 2001-06-12 2011-06-09 Univ Johns Hopkins Med RESERVOIR DEVICE FOR INTRAOCULAR DRUG DELIVERY
US7556621B2 (en) * 2001-06-29 2009-07-07 The Board Of Trustees Of The Leland Stanford Junior University Optically controlled microfluidic chip
EP1283025A1 (en) * 2001-08-10 2003-02-12 Stöckert Instrumente GmbH Ballon occlusion device
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
FR2834446B1 (en) * 2002-01-08 2004-02-13 Ioltechnologie Production EXPANDING MEATIC NAIL
CA2473355C (en) 2002-01-18 2012-01-03 Michael E. Snyder Sustained release ophthalmological device and method of making and using the same
CA2478772C (en) 2002-03-11 2011-01-18 Alcon, Inc. Implantable drug delivery system
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
SI1592408T1 (en) * 2003-01-24 2010-01-29 Psivida Inc Sustained release device and method for ocular delivery of adrenergic agents
KR20050108345A (en) * 2003-01-24 2005-11-16 컨트롤 딜리버리 시스템즈 인코포레이티드 Sustained release and method for ocular delivery of carbonic anhydrase inhibitors
US8404269B2 (en) 2003-04-11 2013-03-26 Michael Snyder Sustained release implantable eye device
CA2536061A1 (en) * 2003-08-22 2005-03-17 Edward J. Ellis Polymeric systems for controlled drug therapy
US20050197614A1 (en) * 2004-03-04 2005-09-08 Wilson Pritchard Occlusive biomedical devices, punctum plugs, and methods of use thereof
US20050232972A1 (en) 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US7922702B2 (en) * 2004-07-02 2011-04-12 Qlt Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
US7117870B2 (en) 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
CA2573892A1 (en) * 2004-07-26 2006-02-09 Clarity Corporation Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US20080038317A1 (en) * 2004-09-10 2008-02-14 Chin-Ming Chang Therapeutic Lacrimal Canalicular Inserts And Related Methods
WO2006039459A1 (en) * 2004-09-30 2006-04-13 Bausch & Lomb Incorporated Capsule for encasing tablets for surgical insertion into the human body
WO2006068898A1 (en) * 2004-12-22 2006-06-29 Bausch & Lomb Incorporated Reusable drug delivery device
US8067189B2 (en) * 2005-09-01 2011-11-29 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV
US20070212397A1 (en) * 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
US7862532B2 (en) * 2005-10-07 2011-01-04 Delta Life Sciences, Inc. Punctum plugs having insertion guides and strengthening beams
JP2009532132A (en) 2006-03-31 2009-09-10 キューエルティー プラグ デリバリー，インク． Nasal tear drainage implant for drug treatment
US7981096B2 (en) * 2006-05-12 2011-07-19 David Castillejos Optic nerve head implant and medication delivery system
US9173773B2 (en) * 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
CN101505694B (en) * 2006-06-21 2012-02-22 庄臣及庄臣视力保护公司 Punctal plugs for the delivery of active agents
CN101505696B (en) * 2006-06-21 2012-11-14 庄臣及庄臣视力保护公司 Punctal plugs for the delivery of active agents
US8969622B2 (en) * 2006-08-23 2015-03-03 Vanderbilt University Dendritic molecular intracellular transporters and methods of making and using same
US20080086101A1 (en) * 2006-08-25 2008-04-10 David Freilich Ophthalmic insert
AU2007339929A1 (en) * 2006-12-26 2008-07-10 Qlt Inc. Drug delivery implants for inhibition of optical defects
UY30883A1 (en) * 2007-01-31 2008-05-31 Alcon Res PUNCTURAL PLUGS AND METHODS OF RELEASE OF THERAPEUTIC AGENTS
US9125807B2 (en) * 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
ES2732555T3 (en) 2007-09-07 2019-11-25 Mati Therapeutics Inc Tear implants and related methods
MX2010002616A (en) 2007-09-07 2010-08-04 Qlt Plug Delivery Inc Drug cores for sustained release of therapeutic agents.
AU2008300018A1 (en) * 2007-09-07 2009-03-19 Qlt Inc. Insertion and extraction tools for lacrimal implants
RU2010112417A (en) * 2007-09-07 2011-10-10 Клт Плаг Диливери, Инк. (Us) DETECTION OF LACRIMAL IMPLANTS
EP2209496B1 (en) 2007-11-05 2019-05-08 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
US11254786B2 (en) 2007-11-05 2022-02-22 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
US20110274620A1 (en) * 2007-11-05 2011-11-10 Harth Eva M Multifunctional degradable nanoparticles with control over size and functionalities
US20130142733A1 (en) 2007-11-05 2013-06-06 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
US20100310622A1 (en) * 2007-12-17 2010-12-09 University Of Florida Research Foundation, Inc. Dry eye treatment by puncta plugs
JP2011510750A (en) 2008-01-29 2011-04-07 クライマン、ギルバート・エイチ Drug delivery device, kit and methods thereof
WO2009105178A2 (en) * 2008-02-18 2009-08-27 Qlt Plug Delivery, Inc. Lacrimal implants and related methods
EP2276471B1 (en) 2008-04-30 2018-08-08 Mati Therapeutics Inc. Composite lacrimal insert and related methods
TWI542338B (en) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 Ophthalmic devices for the controlled release of active agents
MX2010012022A (en) * 2008-05-09 2011-03-15 Qlt Plug Delivery Inc Sustained release delivery of active agents to treat glaucoma and ocular hypertension.
US8894602B2 (en) 2010-09-17 2014-11-25 Johnson & Johnson Vision Care, Inc. Punctal plugs with directional release
EP2303184A4 (en) * 2008-06-24 2013-06-19 Quadra Logic Tech Inc Combination treatment of glaucoma
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
CN102300517A (en) * 2008-12-19 2011-12-28 Qlt股份有限公司 Substance Delivering Punctum Implants And Methods
CA2750381C (en) * 2009-01-23 2021-03-16 Qlt Inc. Sustained released delivery of one or more agents
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
CA3045436A1 (en) 2009-01-29 2010-08-05 Forsight Vision4, Inc. Posterior segment drug delivery
JP5890182B2 (en) 2009-02-12 2016-03-22 インセプト エルエルシー Drug delivery with hydrogel plugs
EP2398431A4 (en) * 2009-02-23 2014-06-11 Mati Therapeutics Inc Lacrimal implants and related methods
WO2010101758A1 (en) 2009-03-03 2010-09-10 Alcon Research, Ltd. Peri-corneal drug delivery device
US20100233241A1 (en) * 2009-03-13 2010-09-16 Vista Scientific Llc Ophthalmic drug delivery system and applications
TWI495459B (en) * 2009-03-31 2015-08-11 Johnson & Johnson Vision Care Punctal plugs
US9421127B2 (en) 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
TW201043211A (en) * 2009-03-31 2010-12-16 Johnson & Johnson Vision Care Inc Punctal plugs
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8808257B2 (en) 2009-08-31 2014-08-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus for pulsatile release of medicaments from a punctal plug
US8469934B2 (en) * 2010-01-27 2013-06-25 Alcon Research, Ltd. Pulsatile peri-corneal drug delivery device
WO2013022801A1 (en) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259352B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
JP2013526572A (en) * 2010-05-17 2013-06-24 アエリエ・ファーマシューティカルズ・インコーポレーテッド Drug delivery device for the delivery of eye treatments
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
WO2012019139A1 (en) 2010-08-05 2012-02-09 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
US9033911B2 (en) 2010-08-05 2015-05-19 Forsight Vision4, Inc. Injector apparatus and method for drug delivery
JP5907966B2 (en) * 2010-08-05 2016-04-26 フォーサイト・ビジョン フォー・インコーポレーテッド Implantable therapy device
US8821457B2 (en) 2010-09-08 2014-09-02 Johnson & Johnson Vision Care, Inc. Punctal plug containing drug formulation
US8591484B2 (en) 2010-09-15 2013-11-26 AlphaMed, Inc. Lacrimal punctum measurement and occlusion
EP2640360A2 (en) 2010-11-19 2013-09-25 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US20120157938A1 (en) 2010-12-16 2012-06-21 Tokarski Jason M Punctal plug with drug core retention features
US9301874B2 (en) 2011-05-06 2016-04-05 Johnson & Johnson Vision Care, Inc. Punctal plugs for controlled release of therapeutic agents
WO2013003620A2 (en) 2011-06-28 2013-01-03 Forsight Vision4, Inc. Diagnostic methods and apparatus
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
CN103889401B (en) 2011-08-29 2017-10-13 Qlt公司 Sustained release delivery activating agent is to treat glaucoma and Bulbi hypertonia
EP3903733A1 (en) 2011-09-16 2021-11-03 ForSight Vision4, Inc. Fluid exchange apparatus
US8721322B2 (en) 2011-11-30 2014-05-13 Johnson & Johnson Vision Care, Inc. Injection molding device and method
CA2858161C (en) 2011-12-05 2020-03-10 Incept, Llc Medical organogel processes and compositions
US8911227B2 (en) 2012-01-11 2014-12-16 Johnson & Johnson Vision Care, Inc. Device for injection molding silicone rubber
US8808256B2 (en) * 2012-01-16 2014-08-19 Johnson & Johnson Vision Care, Inc. Eye drug delivery system
WO2013116061A1 (en) 2012-02-03 2013-08-08 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US20130220346A1 (en) * 2012-02-28 2013-08-29 Victor Lust Balloon punctal plug
CA2897197C (en) 2013-01-15 2022-06-07 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system drug delivery device
EP2968113B8 (en) 2013-03-14 2020-10-28 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
CA2907681C (en) 2013-03-28 2022-11-22 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
US20160302965A1 (en) * 2013-12-06 2016-10-20 Forsight Vision4, Inc. Implantable therapeutic devices
RU2695563C2 (en) 2014-07-15 2019-07-24 Форсайт Вижн4, Инк. Method and device for eye implant delivery
US9474756B2 (en) 2014-08-08 2016-10-25 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
CN111214701A (en) 2014-08-19 2020-06-02 加利福尼亚大学董事会 Implants for localized drug delivery and methods of use thereof
CN114587774A (en) 2014-11-10 2022-06-07 弗赛特影像4股份有限公司 System for treating an eye
AU2015374033B2 (en) 2014-12-31 2020-07-02 Microoptx Inc. Glaucoma treatment devices and methods
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
EP3324902A1 (en) 2015-07-22 2018-05-30 Incept, LLC Coated punctal plug
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) * 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
WO2017059272A1 (en) 2015-09-30 2017-04-06 Microoptx Inc. Dry eye treatment devices and methods
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
US10172740B2 (en) 2015-11-06 2019-01-08 David E Freilich Lacrimal stent
KR20180084104A (en) 2015-11-20 2018-07-24 포사이트 비젼4, 인크. Porous structures for extended release drug delivery devices
WO2017091404A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system for drug delivery
AR108177A1 (en) 2016-04-05 2018-07-25 Forsight Vision4 Inc DEVICES FOR SUPPLY OF IMPLANTABLE OCULAR DRUGS
JP7003110B2 (en) 2016-04-20 2022-01-20 ドーズ メディカル コーポレーション Bioabsorbable eye drug delivery device
JP7054211B2 (en) 2016-05-20 2022-04-13 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイト Lacrimal gland drug feeding device
BR112020010053A2 (en) 2017-11-21 2020-11-03 Forsight Vision4, Inc. fluid change device for expandable door release system and methods of using it
JP7451732B2 (en) 2020-02-06 2024-03-18 オキュラ セラピューティクス，インコーポレイテッド Compositions and methods for treating eye diseases
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
WO2021195163A1 (en) 2020-03-25 2021-09-30 Ocular Therapeutix, Inc. Ocular implant containing a tyrosine kinase inhibitor
KR20230109623A (en) 2020-10-05 2023-07-20 맥스 바이올로지 컴퍼니 리미티드 Cannabinoid-containing compositions and uses for treating and preventing diseases
CN114652488A (en) * 2022-03-22 2022-06-24 海思盖德(苏州)生物医学科技有限公司 Intraocular implant and implant surface compound type medicine coating process

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626940A (en) 1969-05-02 1971-12-14 Alza Corp Ocular insert
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3641237A (en) 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US3993071A (en) 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US3826258A (en) 1972-02-07 1974-07-30 S Abraham Gradual release medicine carrier
US3962414A (en) 1972-04-27 1976-06-08 Alza Corporation Structured bioerodible drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3963025A (en) 1974-09-16 1976-06-15 Alza Corporation Ocular drug delivery device
US3949750A (en) * 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US3992071A (en) 1975-04-01 1976-11-16 The United States Of America As Represented By The Secretary Of The Army Processes for activating S-1 cathode
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4834979A (en) * 1981-06-29 1989-05-30 Alza Corporation Medical bandage for administering beneficial drug
US5053030A (en) 1984-11-07 1991-10-01 Herrick Robert S Intracanalicular implant for horizontal canalicular blockade treatment of the eye
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4994273A (en) 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US4923699A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US4875602A (en) * 1988-06-15 1989-10-24 Triad Direct Incorporated Self-contained liquid dispensing device
CA2031960C (en) * 1989-12-19 2002-05-28 Daniel Py Ocular treatment apparatus
US5171270A (en) 1990-03-29 1992-12-15 Herrick Robert S Canalicular implant having a collapsible flared section and method
US5417682A (en) 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5283063A (en) 1992-01-31 1994-02-01 Eagle Vision Punctum plug method and apparatus
US5417651A (en) 1993-07-01 1995-05-23 Guena; Nicolas Punctum plug and monocanalicular probe for lacrimal pathology
US5423777A (en) * 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
US5725493A (en) * 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5723005A (en) 1995-06-07 1998-03-03 Herrick Family Limited Partnership Punctum plug having a collapsible flared section and method

Also Published As

Publication number Publication date
DE60035979D1 (en) 2007-09-27
US6196993B1 (en) 2001-03-06
DK1178779T3 (en) 2007-12-10
PT1178779E (en) 2007-10-02
DE60035979T2 (en) 2007-12-20
ATE459343T1 (en) 2010-03-15
EP1178779A4 (en) 2005-01-12
DE60043959D1 (en) 2010-04-15
ES2340616T3 (en) 2010-06-07
EP1891942A1 (en) 2008-02-27
EP1891942B1 (en) 2010-03-03
EP1178779A1 (en) 2002-02-13
WO2000062760A1 (en) 2000-10-26
EP1178779B1 (en) 2007-08-15
PT1891942E (en) 2010-04-21
ES2288471T3 (en) 2008-01-16
ATE369843T1 (en) 2007-09-15
AU4205900A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
DK1891942T3 (en) Ophthalmic action and method for prolonged delivery of a drug to the eye
US4908024A (en) Ocular self-treatment apparatus and method
CA2422264A1 (en) Customized vision correction method and business
CN206515567U (en) One kind carries property of medicine contact lens
WO2004014218A3 (en) Implantable ocular pump to reduce intraocular pressure
CA2433849A1 (en) Glaucoma treatment device and method
EP2116215A3 (en) Shunt device for treating glaucoma
WO2008024982A3 (en) Ophthalmic insert
BR0110944A (en) Method of preselecting a polymerizable fluid formed within an intraocular lens
MXPA05009020A (en) Teledioptic lens system and method for using the same.
WO2016031535A1 (en) Device placed under eyelid
US8235053B2 (en) Implantable punctal plug
WO2003015667A8 (en) Method and intra sclera implant for treatment of glaucoma and presbyopia
WO2016031093A1 (en) Ocular insert device
WO2002049611A3 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
EP1245233A4 (en) System for stabilizing lacrimal fluid layer
CN209808717U (en) Pupil shrinking device
CN216136506U (en) Atomizing glasses that multimode switches
CN2502672Y (en) Porous perfusion anterior chamber maintaining apparatus
JP2673537B2 (en) Ocular treatment substance self-administration device
CN217409130U (en) Drug delivery contact lens and ophthalmic drug delivery device
DOANE Methods of ophthalmic fluid delivery
Goldberg Corneal lenses before RGP, or those were the good (?) old days
CN116459069A (en) Administration contact lens and ophthalmic administration device
RU98116904A (en) METHOD FOR TREATING CORNERAL HAZELDS AFTER VIRAL KERATITIS